US Diagnostic plans merger

Article

US Diagnostic has a tentative agreement to merge with International Radiology Group. According to terms of a letter of agreement between the two companies, USD would acquire all of the fully diluted membership units of IRG for 49% of the issued shares of

US Diagnostic has a tentative agreement to merge with International Radiology Group. According to terms of a letter of agreement between the two companies, USD would acquire all of the fully diluted membership units of IRG for 49% of the issued shares of the combined entity, $5 million in cash, $5 million in a five-year subordinated unsecured debenture, and performance-based warrants. The transaction is subject to due diligence and other conditions, including regulatory approval and shareholder consent. If the merger goes through, which could happen in the second quarter of 2001, representatives of IRG will have a majority of the board seats of the combined entity.

US Diagnostic, an independent provider of radiology services, owns, operates, or manages 47 fixed sites in 12 states. IRG and its subsidiary American Imaging Management manage radiology benefits for managed-care organizations covering approximately three million lives.

Recent Videos
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.